SMARCB1 and rhabdoid tumor: On a brighter note, inhibition of the H3K36 demethylase KDM2A was recently demonstrated to rescue resistance to EZH2 inhibition conferred by loss of the H3K36 methyltransferase NSD1 in SMARCB1-deficient rhabdoid tumor cell lines, as discussed above (27).